Express Scripts, St. Louis, announced it will purchase Indianapolis-based WellPoint's NextRx subsidiaries for $4.7 billion in a deal expected to close by the end of the year.
Read more soon at modernhealthcare.com and in Health IT Strategist.
Comment on this story and read the Your Views: HITS Reader Blog.